Published online before print February 6, 2006, doi: 10.1161/CIRCULATIONAHA.105.561571
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2006;113:776-782.)
© 2006 American Heart Association, Inc.
Arrhythmia/Electrophysiology |
Are Implantable Cardioverter Defibrillator Shocks a Surrogate for Sudden Cardiac Death in Patients With Nonischemic Cardiomyopathy?
From the Department of Medicine, Medical College of Virginia (K.A.E.), Richmond, Va; St. Francis Hospital (J.H.L.), Roslyn, NY; Johns Hopkins Hospital (R.D.B.), Baltimore, Md; University of Rochester (J.P.D.), Rochester, NY; Morristown Memorial Hospital (S.L.W.), Morristown, NJ; VA Pittsburgh Healthcare System (A. Shalaby), Pittsburgh, Pa; and Bluhm Cardiovascular Institute-Clinical Trials Unit, Northwestern Memorial Hospital (E.G., A. Schaechter, H.S., A.K.), Chicago, Ill.
Correspondence to Kenneth A. Ellenbogen, MD, Medical College of Virginia, PO Box 980053, Richmond, VA 23298-0053. E-mail kellenbogen{at}pol.net or kaellenb@vcu.edu
Received May 10, 2005; revision received October 16, 2005; accepted October 24, 2005.
Background— Ventricular tachyarrhythmias long enough to cause implantable cardioverter defibrillator (ICD) shocks are generally thought to progress to cardiac arrest. In previous ICD trials, shocks have been considered an appropriate surrogate for sudden cardiac death (SCD) because the number of shocks has been thought to be equivalent to the mortality excess in patients without ICDs. The practice of equating ICD shocks with mortality is controversial and has not been validated critically.
Methods and Results— The Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) trial was a prospective, randomized, multicenter trial of ICD therapy in 458 patients with nonischemic cardiomyopathy. Patients were randomized to receive standard medical therapy (STD) or STD plus an ICD. Shock electrograms were reviewed, and the cause of death was evaluated by a separate blinded events committee. There were 15 SCD or cardiac arrests in the STD group and only 3 in the ICD arm. In contrast, of the 229 patients randomized to an ICD, 33 received 70 appropriate ICD shocks. Patients in the ICD arm were more likely to have an arrhythmic event (ICD shock plus SCD) than patients in the STD arm (hazard ratio 2.12, 95% CI 1.153 to 3.893, P=0.013). The number of arrhythmic events when one includes syncope as a potential arrhythmic event was similar in both groups (hazard ratio 1.20, 95% CI 0.774 to 1.865, P=0.414). Approximately the same number of total events was noted in each arm when we compared syncope plus SCD/cardiac arrest in the STD arm with SCD plus ICD shocks plus syncope in the ICD arm.
Conclusions— Appropriate ICD shocks occur more frequently than SCD in patients with nonischemic cardiomyopathy. This suggests that episodes of nonsustained ventricular tachycardia frequently terminate spontaneously in such patients.
CLINICAL PERSPECTIVE
Related Article:
-
Issue Highlights
Circulation 2006 113: 763.[Extract] [Full Text]
This article has been cited by other articles:
 |
|
 |
|
  P. A. Scott, J. Barry, P. R. Roberts, and J. M. Morgan Brain natriuretic peptide for the prediction of sudden cardiac death and ventricular arrhythmias: a meta-analysis Eur J Heart Fail, October 1, 2009; 11(10): 958 - 966. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Myerburg, V. Reddy, and A. Castellanos Indications for implantable cardioverter-defibrillators based on evidence and judgment. J. Am. Coll. Cardiol., August 25, 2009; 54(9): 747 - 763. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Zaman, G. Sivagangabalan, A. Narayan, A. Thiagalingam, D. L. Ross, and P. Kovoor Outcomes of Early Risk Stratification and Targeted Implantable Cardioverter-Defibrillator Implantation After ST-Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention Circulation, July 21, 2009; 120(3): 194 - 200. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. G. Tereshchenko, B. J. Fetics, P. P. Domitrovich, B. D. Lindsay, and R. D. Berger Prediction of Ventricular Tachyarrhythmias by Intracardiac Repolarization Variability Analysis Circ Arrhythm Electrophysiol, June 1, 2009; 2(3): 276 - 284. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Grace Implantable defibrillators in hypertrophic cardiomyopathy Heart, May 1, 2009; 95(9): 695 - 696. [Full Text] [PDF]
|
|
|
|
|
|
E. J. Rashba Anger management may save your life new insights into emotional precipitants of ventricular arrhythmias. J. Am. Coll. Cardiol., March 3, 2009; 53(9): 779 - 781. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Plummer Implantable cardioverter defibrillator therapy for non-ischaemic cardiomyopathy. What is the role of programmed electrical stimulation? Europace, March 1, 2009; 11(3): 273 - 275. [Full Text] [PDF]
|
|
|
|
|
|
O. Costantini, S. H. Hohnloser, M. M. Kirk, B. B. Lerman, J. H. Baker II, B. Sethuraman, M. M. Dettmer, D. S. Rosenbaum, and for the ABCD Trial Investigators The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention. J. Am. Coll. Cardiol., February 10, 2009; 53(6): 471 - 479. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Chow, D. J. Kereiakes, J. Onufer, A. Woelfel, S. Gursoy, B. J. Peterson, M. L. Brown, W. Pu, D. G. Benditt, and on behalf of the MASTER Trial Investigators Does Microvolt T-Wave Alternans Testing Predict Ventricular Tachyarrhythmias in Patients With Ischemic Cardiomyopathy and Prophylactic Defibrillators?: The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) Trial J. Am. Coll. Cardiol., November 11, 2008; 52(20): 1607 - 1615. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Rosenbaum T-Wave Alternans in the Sudden Cardiac Death in Heart Failure Trial Population: Signal or Noise? Circulation, November 11, 2008; 118(20): 2015 - 2018. [Full Text] [PDF]
|
|
|
|
|
|
J. K. Triedman Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD?: Implantable Cardioverter Defibrillator Implantation Guidelines Based Solely on Left Ventricular Ejection Fraction Do Not Apply to Adults With Congenital Heart Disease Circ Arrhythm Electrophysiol, October 1, 2008; 1(4): 307 - 316. [Full Text] [PDF]
|
|
|
|
|
|
M. R. de Sousa, C. A. Morillo, F. T. Rabelo, A. M. N. Filho, and A. L.P. Ribeiro Non-sustained ventricular tachycardia as a predictor of sudden cardiac death in patients with left ventricular dysfunction: A meta-analysis Eur J Heart Fail, October 1, 2008; 10(10): 1007 - 1014. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Tung, P. Zimetbaum, and M. E. Josephson A Critical Appraisal of Implantable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death J. Am. Coll. Cardiol., September 30, 2008; 52(14): 1111 - 1121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. K. Witte, C. B. Pepper, J. C. Cowan, J. D. Thomson, K. M. English, and M. E. Blackburn Implantable cardioverter-defibrillator therapy in adult patients with tetralogy of Fallot Europace, August 1, 2008; 10(8): 926 - 930. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. K. Witte, C. B. Pepper, J. D. Thomson, and K. M. English Letter by Witte et al Regarding Article, "Implantable Cardioverter-Defibrillators in Tetralogy of Fallot" Circulation, July 29, 2008; 118(5): e99 - e99. [Full Text] [PDF]
|
|
|
|
 |
|
 R. C. Saumarez, M. Pytkowski, M. Sterlinski, J. P. Bourke, J. R. Clague, S. M. Cobbe, D. T. Connelly, M. J. Griffith, P. P. McKeown, K. McLeod, et al. Paced ventricular electrogram fractionation predicts sudden cardiac death in hypertrophic cardiomyopathy Eur. Heart J., July 1, 2008; 29(13): 1653 - 1661. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. B. Pavri, M. B. Hillis, H. Subacius, G. E. Brumberg, A. Schaechter, J. H. Levine, A. Kadish, and for the Defibrillators in Nonischemic Cardiomyopat Prognostic Value and Temporal Behavior of the Planar QRS-T Angle in Patients With Nonischemic Cardiomyopathy Circulation, June 24, 2008; 117(25): 3181 - 3186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Khairy, L. Harris, M. J. Landzberg, S. Viswanathan, A. Barlow, M. A. Gatzoulis, S. M. Fernandes, L. Beauchesne, J. Therrien, P. Chetaille, et al. Implantable Cardioverter-Defibrillators in Tetralogy of Fallot Circulation, January 22, 2008; 117(3): 363 - 370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Almendral and M. E. Josephson All Patients With Hemodynamically Tolerated Postinfarction Ventricular Tachycardia Do Not Require an Implantable Cardioverter-Defibrillator Circulation, September 4, 2007; 116(10): 1204 - 1212. [Full Text] [PDF]
|
|
|
|
|
|
B. London, C. Albert, M. E. Anderson, W. R. Giles, D. R. Van Wagoner, E. Balk, G. E. Billman, M. Chung, W. Lands, A. Leaf, et al. Omega-3 Fatty Acids and Cardiac Arrhythmias: Prior Studies and Recommendations for Future Research: A Report from the National Heart, Lung, and Blood Institute and Office of Dietary Supplements Omega-3 Fatty Acids and Their Role in Cardiac Arrhythmogenesis Workshop Circulation, September 4, 2007; 116(10): e320 - e335. [Full Text] [PDF]
|
|
|
|
|
|
A. E. Epstein, C. A. Baessler, A. B. Curtis, N.A. M. Estes III, B. J. Gersh, B. Grubb, and L. B. Mitchell Addendum to "Personal and Public Safety Issues Related to Arrhythmias That May Affect Consciousness: Implications for Regulation and Physician Recommendations: A Medical/ Scientific Statement From the American Heart Association and the North American Society of Pacing and Electrophysiology" Public Safety Issues in Patients With Implantable Defibrillators A Scientific Statement From the American Heart Association and the Heart Rhythm Society Circulation, March 6, 2007; 115(9): 1170 - 1176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Christ, J. Sharkova, S. Bayrakcioglu, I. Herzum, C. Mueller, and W. Grimm B-type natriuretic peptide levels predict event-free survival in patients with implantable cardioverter defibrillators Eur J Heart Fail, March 1, 2007; 9(3): 272 - 279. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Goldberger, H. Subacius, A. Schaechter, A. Howard, R. Berger, A. Shalaby, J. Levine, A. H. Kadish, and for the DEFINITE Investigators Effects of Statin Therapy on Arrhythmic Events and Survival in Patients With Nonischemic Dilated Cardiomyopathy J. Am. Coll. Cardiol., September 19, 2006; 48(6): 1228 - 1233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. W. Stevenson Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Death in Heart Failure: Are There Enough Bangs for the Bucks? Circulation, July 11, 2006; 114(2): 101 - 103. [Full Text] [PDF]
|
|
|
|
 |
|
 Is an ICD Shock a Surrogate for Sudden Death? Journal Watch Emergency Medicine, March 14, 2006; 2006(314): 9 - 9. [Full Text]
|
|
|
|
|
|
S. J. Connolly Use and Misuse of Surrogate Outcomes in Arrhythmia Trials Circulation, February 14, 2006; 113(6): 764 - 766. [Full Text] [PDF]
|
|